查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2036138

2026年全球腫瘤外泌體分析市場報告

Tumor Exosome Profiling Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤外泌體分析市場發展迅速。預計該市場規模將從2025年的11.3億美元成長到2026年的13.2億美元，複合年成長率（CAGR）為16.9%。過去幾年成長要素包括癌症發病率上升、分子生物學技術的進步、液態生物檢體方法的日益普及、腫瘤學研究經費的增加以及對非侵入性診斷工具的需求。

預計未來幾年腫瘤外泌體分析市場將快速成長，到2030年將達到24.9億美元，複合年成長率（CAGR）為17.1%。預測期內的成長要素包括人工智慧和生物資訊學在腫瘤外泌體分析中的應用、個人化醫療解決方案的開發、診斷檢查室的擴張、高通量腫瘤外泌體分析平台的普及以及癌症生物標記發現的進展。預測期內的關鍵趨勢包括與液態生物檢體的整合、高通量腫瘤外泌體分析、自動化樣本製備、多體學數據分析以及個人化癌症治療。

預計未來幾年，癌症發生率的上升將推動腫瘤外泌體分析市場的成長。癌症是一組疾病，其特徵是異常細胞不受控制地增殖和分裂，這些細胞可以侵入周圍組織並轉移到身體的其他部位。癌症發生率的上升歸因於不健康的生活方式，例如營養不良、缺乏運動、吸煙和過量飲酒，所有這些都會增加各種癌症的風險。腫瘤外泌體分析透過分析體液中腫瘤來源的外泌體來幫助控制癌症，從而實現早期檢測、監測腫瘤進展並指南個人化治療。例如，截至2024年2月，總部位於瑞士、專門從事全球衛生政策和公共衛生舉措的國際組織－世界衛生組織（世衛組織）預測，到2050年，新增癌症病例將超過3500萬例，比2022年估計的2000萬例成長77%。因此，癌症發生率的上升正在推動腫瘤外泌體分析市場的快速成長。

腫瘤外泌體分析市場的領導者正致力於開發創新解決方案，例如基於液態生物檢體活體組織切片的外泌體檢測，以實現癌症的早期檢測和個人化治療的監測。基於液態生物檢體的外泌體檢測是一種血液檢測，可檢測癌細胞釋放的微小囊泡——外泌體，使醫生無需進行侵入性組織切片檢查即可識別和後續觀察癌症。例如，2024年6月，美國生技公司Mercy BioAnalytics Inc.與英國大學學院（UCL）合作推出了「Mercy Halo卵巢癌篩檢測試」。這是一種新一代細胞外囊泡液體活體組織切片方法，旨在透過檢測法共定位於單一腫瘤來源囊泡上的多種癌症生物標記物，利用少量血液樣本和基於定量聚合酵素鏈鎖反應（ qPCR）的檢測方法，識別無症狀停經停經後女性的卵巢癌，從而在臨床診斷前數年提供高靈敏度和特異性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球腫瘤外泌體分析市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫療
    • 工業4.0和智慧製造
    • 人工智慧和自主智慧
    • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 主要趨勢
    • 液態切片整合
    • 高通量外泌體分析
    • 自動化樣品製備
    • 多體學資料分析
    • 個人化癌症治療

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 研究機構
  • 診斷檢查室
  • 製藥公司
  • 學術和政府附屬研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球腫瘤外泌體分析市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球腫瘤外泌體分析市場：規模、對比及成長率分析
  • 全球腫瘤外泌體分析市場表現：規模與成長，2020-2025年
  • 全球腫瘤外泌體分析市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 試劑盒和試劑、儀器、軟體和服務
  • 依樣本類型
  • 血液、尿液、唾液和其他檢體
  • 透過使用
  • 癌症的診斷、預後診斷、治療和研究。
  • 最終用戶
  • 醫院、診所、研究機構、診斷檢查室和其他最終用戶
  • 細分（按類型）：試劑盒和試劑
  • 分離試劑盒、檢測試劑盒、定量試劑盒、標記試劑、抗體
  • 細分：按類型：設備
  • 流式細胞儀、奈米顆粒追蹤分析儀、超速離心機、微流體裝置、聚合酵素鏈鎖反應（PCR）系統。
  • 細分：依類型：軟體
  • 數據分析軟體、視覺化軟體、生物資訊平台、統計建模軟體、外泌體追蹤軟體
  • 細分：依類型：服務
  • 樣品製備服務、外泌體分離服務、分子譜分析服務、數據分析服務、客製化檢測開發服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 腫瘤外泌體分析市場：競爭格局及市場佔有率（2024年）
  • 腫瘤外泌體分析市場：公司估值矩陣
  • 腫瘤外泌體分析市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Lonza Group Ltd.
    • NanoFCM Inc.
    • QIAGEN NV
    • Bio-Techne Corporation

第37章 其他大型企業和創新企業

  • Miltenyi Biotec BV And Co. KG, Aethlon Medical Inc., Cusabio Technology LLC, Norgen Biotek Corp., Kimera Labs Inc, Diagenode Inc, Creative Biolabs Inc, Izon Science Ltd., System Biosciences LLC, Mercy Bioanalytics Inc, MtoZ Biolab, Capital Biosciences Inc., ExoCan Healthcare Technologies Private Limited, INOVIQ Ltd, Codiak BioSciences Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年腫瘤外泌體分析市場：提供新機會的國家
  • 2030年腫瘤外泌體分析市場：充滿新機會的細分領域
  • 2030年腫瘤外泌體分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: ME5MTEPX01_G26Q2

Tumor exosome profiling involves the analysis and characterization of exosomes, which are small extracellular vesicles released by tumor cells containing molecular information such as proteins, RNA, and DNA. This profiling provides insights into tumor biology, helps identify biomarkers, and supports the development of diagnostic or therapeutic strategies for cancer management.

The key product types of tumor exosome profiling include kits and reagents, instruments, software, and services. Kits and reagents isolate, detect, and analyze exosomes from biological samples, enabling accurate disease diagnostics and research. Sample types include blood, urine, saliva, and others. Applications include cancer diagnostics, prognostics, therapeutics, and research, serving hospitals, clinics, research institutes, diagnostic laboratories, and other end users.

Tariffs have influenced the tumor exosome profiling market by raising the cost of importing specialized instruments, kits, and reagents required for profiling. This has primarily impacted segments such as instruments and kits, especially in regions like North America and Europe that rely heavily on imports for advanced laboratory equipment. However, tariffs are encouraging local manufacturing and innovation, driving the development of cost-efficient, domestically produced solutions and fostering market resilience.

The tumor exosome profiling market research report is one of a series of new reports from The Business Research Company that provides tumor exosome profiling market statistics, including tumor exosome profiling industry global market size, regional shares, competitors with a tumor exosome profiling market share, detailed tumor exosome profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor exosome profiling industry. This tumor exosome profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor exosome profiling market size has grown rapidly in recent years. It will grow from $1.13 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to growing cancer prevalence, advances in molecular biology techniques, increasing adoption of liquid biopsy methods, rising research funding for oncology, demand for non-invasive diagnostic tools.

The tumor exosome profiling market size is expected to see rapid growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to integration of ai and bioinformatics in exosome profiling, development of personalized medicine solutions, expansion of diagnostic laboratories, adoption of high-throughput exosome analysis platforms, growth in cancer biomarker discovery. Major trends in the forecast period include liquid biopsy integration, high-throughput exosome analysis, automated sample preparation, multi-omics data profiling, personalized cancer therapeutics.

The increasing prevalence of cancer is anticipated to drive the growth of the tumor exosome profiling market in the coming years. Cancer encompasses a group of diseases characterized by uncontrolled proliferation and division of abnormal cells, which can invade nearby tissues and metastasize to other body regions. The rise in cancer prevalence is attributed to unhealthy lifestyles, including poor nutrition, physical inactivity, smoking, and excessive alcohol consumption, all of which elevate the risk of various cancer types. Tumor exosome profiling aids cancer management by enabling early detection, monitoring tumor progression, and guiding personalized therapy through analysis of tumor-derived exosomes in body fluids. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, over 35 million new cancer cases are projected in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is propelling rapid growth in the tumor exosome profiling market.

Key companies operating in the tumor exosome profiling market are focusing on developing innovative solutions, such as liquid biopsy-based exosome assays, to enable early cancer detection and personalized therapy monitoring. A liquid biopsy-based exosome assay is a blood test that detects tiny vesicles called exosomes released by tumor cells, allowing doctors to identify and monitor cancer without invasive tissue biopsies. For example, in June 2024, Mercy BioAnalytics Inc., a US-based biotechnology company, partnered with University College London (UCL), a UK-based university, to launch the Mercy Halo Ovarian Cancer Screening Test, a next-generation extracellular vesicle liquid biopsy designed to identify ovarian cancer in asymptomatic, postmenopausal women by detecting multiple co-localized cancer biomarkers on individual tumor-derived vesicles using a low-volume blood sample and quantitative polymerase chain reaction (qPCR)-based readout, offering high sensitivity and specificity several years before clinical diagnosis.

In September 2025, MDxHealth SA, a Belgium-based healthcare technology company, acquired Exosome Diagnostics, Inc. from Bio Techne Corporation for $15 million. With this acquisition, MDxHealth seeks to expand its liquid-based diagnostic offerings and reinforce its leadership in prostate cancer diagnostics by integrating ExoDx prostate cancer testing and associated clinical laboratory assets. Exosome Diagnostics Inc. is a US-based healthcare technology company that specializes in comprehensive, proprietary tumor exosome profiling and liquid biopsy services.

Major companies operating in the tumor exosome profiling market are Thermo Fisher Scientific Inc., Lonza Group Ltd., NanoFCM Inc., QIAGEN N.V., Bio-Techne Corporation, Miltenyi Biotec B.V. And Co. KG, Aethlon Medical Inc., Cusabio Technology LLC, Norgen Biotek Corp., Kimera Labs Inc, Diagenode Inc., Creative Biolabs Inc, Izon Science Ltd., System Biosciences LLC, Mercy Bioanalytics Inc, MtoZ Biolab, Capital Biosciences Inc., ExoCan Healthcare Technologies Private Limited, INOVIQ Ltd, Codiak BioSciences Inc.

North America was the largest region in the tumor exosome profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor exosome profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tumor exosome profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor exosome profiling market consists of revenues earned by entities by providing services such as exosome isolation and purification, next-generation sequencing (ngs) services, custom exosome research services, exosome biomarker discovery and validation, and exosome-based liquid biopsy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor exosome profiling market also includes sales of exosome analysis and characterization instruments, bioinformatics software and analytics tools, affinity based isolation columns and spin column kits, high throughput microfluidic platforms, and exosome biomarker profiling libraries and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Exosome Profiling Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tumor exosome profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor exosome profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor exosome profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Kits And Reagents; Instruments; Software; Services
  • 2) By Sample Type: Blood; Urine; Saliva; Other Sample Types
  • 3) By Application: Cancer Diagnostics; Prognostics; Therapeutics; Research
  • 4) By End-User: Hospitals And Clinics; Research Institutes; Diagnostic Laboratories; Other End-Users
  • Subsegments:
  • 1) By Kits And Reagents: Isolation Kits; Detection Kits; Quantification Kits; Labeling Reagents; Antibodies
  • 2) By Instruments: Flow Cytometers; Nanoparticle Tracking Analyzers; Ultracentrifuges; Microfluidic Devices; Polymerase Chain Reaction Machines (PCR) Machines
  • 3) By Software: Data Analysis Software; Visualization Software; Bioinformatics Platforms; Statistical Modeling Software; Exosome Tracking Software
  • 4) By Services: Sample Preparation Services; Exosome Isolation Services; Molecular Profiling Services; Data Analysis Services; Custom Assay Development Services
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group Ltd.; NanoFCM Inc.; QIAGEN N.V.; Bio-Techne Corporation; Miltenyi Biotec B.V. And Co. KG; Aethlon Medical Inc.; Cusabio Technology LLC; Norgen Biotek Corp.; Kimera Labs Inc; Diagenode Inc.; Creative Biolabs Inc; Izon Science Ltd.; System Biosciences LLC; Mercy Bioanalytics Inc; MtoZ Biolab; Capital Biosciences Inc.; ExoCan Healthcare Technologies Private Limited; INOVIQ Ltd; Codiak BioSciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tumor Exosome Profiling Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tumor Exosome Profiling Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tumor Exosome Profiling Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tumor Exosome Profiling Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Liquid Biopsy Integration
    • 4.2.2 High-Throughput Exosome Analysis
    • 4.2.3 Automated Sample Preparation
    • 4.2.4 Multi-Omics Data Profiling
    • 4.2.5 Personalized Cancer Therapeutics

5. Tumor Exosome Profiling Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Research Institutes
  • 5.3 Diagnostic Laboratories
  • 5.4 Pharmaceutical Companies
  • 5.5 Academic And Government Research Centers

6. Tumor Exosome Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tumor Exosome Profiling Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tumor Exosome Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tumor Exosome Profiling Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tumor Exosome Profiling Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tumor Exosome Profiling Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tumor Exosome Profiling Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tumor Exosome Profiling Market Segmentation

  • 9.1. Global Tumor Exosome Profiling Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits And Reagents, Instruments, Software, Services
  • 9.2. Global Tumor Exosome Profiling Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Saliva, Other Sample Types
  • 9.3. Global Tumor Exosome Profiling Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnostics, Prognostics, Therapeutics, Research
  • 9.4. Global Tumor Exosome Profiling Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Other End-Users
  • 9.5. Global Tumor Exosome Profiling Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Isolation Kits, Detection Kits, Quantification Kits, Labeling Reagents, Antibodies
  • 9.6. Global Tumor Exosome Profiling Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Flow Cytometers, Nanoparticle Tracking Analyzers, Ultracentrifuges, Microfluidic Devices, Polymerase Chain Reaction Machines (PCR) Machines
  • 9.7. Global Tumor Exosome Profiling Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Visualization Software, Bioinformatics Platforms, Statistical Modeling Software, Exosome Tracking Software
  • 9.8. Global Tumor Exosome Profiling Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sample Preparation Services, Exosome Isolation Services, Molecular Profiling Services, Data Analysis Services, Custom Assay Development Services

10. Tumor Exosome Profiling Market Regional And Country Analysis

  • 10.1. Global Tumor Exosome Profiling Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tumor Exosome Profiling Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tumor Exosome Profiling Market

  • 11.1. Asia-Pacific Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tumor Exosome Profiling Market

  • 12.1. China Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tumor Exosome Profiling Market

  • 13.1. India Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tumor Exosome Profiling Market

  • 14.1. Japan Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tumor Exosome Profiling Market

  • 15.1. Australia Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tumor Exosome Profiling Market

  • 16.1. Indonesia Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tumor Exosome Profiling Market

  • 17.1. South Korea Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tumor Exosome Profiling Market

  • 18.1. Taiwan Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tumor Exosome Profiling Market

  • 19.1. South East Asia Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tumor Exosome Profiling Market

  • 20.1. Western Europe Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tumor Exosome Profiling Market

  • 21.1. UK Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tumor Exosome Profiling Market

  • 22.1. Germany Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tumor Exosome Profiling Market

  • 23.1. France Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tumor Exosome Profiling Market

  • 24.1. Italy Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tumor Exosome Profiling Market

  • 25.1. Spain Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tumor Exosome Profiling Market

  • 26.1. Eastern Europe Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tumor Exosome Profiling Market

  • 27.1. Russia Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tumor Exosome Profiling Market

  • 28.1. North America Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tumor Exosome Profiling Market

  • 29.1. USA Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tumor Exosome Profiling Market

  • 30.1. Canada Tumor Exosome Profiling Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tumor Exosome Profiling Market

  • 31.1. South America Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tumor Exosome Profiling Market

  • 32.1. Brazil Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tumor Exosome Profiling Market

  • 33.1. Middle East Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tumor Exosome Profiling Market

  • 34.1. Africa Tumor Exosome Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tumor Exosome Profiling Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tumor Exosome Profiling Market Regulatory and Investment Landscape

36. Tumor Exosome Profiling Market Competitive Landscape And Company Profiles

  • 36.1. Tumor Exosome Profiling Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tumor Exosome Profiling Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tumor Exosome Profiling Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. NanoFCM Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tumor Exosome Profiling Market Other Major And Innovative Companies

  • Miltenyi Biotec B.V. And Co. KG, Aethlon Medical Inc., Cusabio Technology LLC, Norgen Biotek Corp., Kimera Labs Inc, Diagenode Inc, Creative Biolabs Inc, Izon Science Ltd., System Biosciences LLC, Mercy Bioanalytics Inc, MtoZ Biolab, Capital Biosciences Inc., ExoCan Healthcare Technologies Private Limited, INOVIQ Ltd, Codiak BioSciences Inc.

38. Global Tumor Exosome Profiling Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Tumor Exosome Profiling Market

41. Tumor Exosome Profiling Market High Potential Countries, Segments and Strategies

  • 41.1 Tumor Exosome Profiling Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Tumor Exosome Profiling Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Tumor Exosome Profiling Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer